WebJan 10, 2024 · swelling of the face, lips, tongue, or throat, pain or burning during urination, severe headache, blurred vision, and. pounding in the neck or ears. Rare side effects of Mirabegron include: none. This is not a complete list of side effects and other serious side effects or health problems may occur as a result of the use of this drug. A generic version of Myrbetriq has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Myrbetriq and have been approved by the FDA: See more Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims. 1. Pharmaceutical composition containing mirabegron Patent 10,058,536 Issued: … See more Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. … See more Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Medical Disclaimer See more
Myrbetriq (mirabegron): Basics, Side Effects & Reviews - GoodRx
WebJul 15, 2024 · High blood pressure, urinary tract infections, nasal congestion, headache, and upper respiratory tract infections are the most common side effects reported. … WebThis medication is used to treat certain bladder problems ( overactive bladder, neurogenic detrusor overactivity). Overactive bladder is a problem with how your bladder stores … thunder tex magenta
Myrbetriq: 7 things you should know - Drugs.com
WebAug 12, 2024 · A generic drug is an exact copy of the active drug in a brand-name medication. Generics usually cost less than brand-name drugs. Myrbetriq contains the active drug mirabegron. WebJun 19, 2013 · Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 19, 2013 ... June 19, 2013. Drug Name Review Type Class Manufacturer; Invokana: New Drug Initial Review: SGLT2 Inhibitor : Janssen: Pertzye: New Drug Initial Review: Pancreatic Enzyme: Digestive Care, Inc: Vascepa: New Drug Initial Review: Lipotropic: … WebMyrbetriq is a prescription medicine for adults approved by the U.S. Food and Drug Administration (FDA) to treat the overactive bladder symptoms of urgency, frequency, and leakage. Myrbetriq was shown in studies to be … thunder tex account